The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Blood transfusion at delivery and risk of subsequent malignant lymphoma in the mother

På svenska

Author

Summary, in English

BACKGROUND AND OBJECTIVES: Blood transfusion has been shown to be a risk factor for non-Hodgkin's lymphoma (NHL).

MATERIALS AND METHODS: In a cohort of 77,928 women with bleeding complications at delivery in the period of 1973-1986, subsequent NHL cases were identified and the number was compared with the number expected from national incidence rates. In a case-control study the proportion of transfused NHL cases was compared with the proportion of transfused controls.

RESULTS: The observed number of NHL in the cohort was 18 versus 22.0 expected. Information on transfusion was obtained for 15 of the NHL cases and none (0%) was transfused versus 32 out of 136 controls (23%).

CONCLUSIONS: Blood transfusion at delivery is not a risk factor for NHL. The immune tolerance induced by pregnancy may reduce the risk of NHL associated with the transfusion of allogeneic blood cells.

Publishing year

1998

Language

English

Pages

145-148

Publication/Series

Vox Sanguinis

Volume

75

Issue

2

Document type

Journal article

Publisher

Wiley-Blackwell

Topic

  • Cancer and Oncology

Keywords

  • Adult
  • Blood Transfusion
  • Case-Control Studies
  • Cohort Studies
  • Delivery, Obstetric
  • Female
  • Hodgkin Disease
  • Humans
  • Incidence
  • Lymphoma, Non-Hodgkin
  • Postpartum Hemorrhage
  • Pregnancy
  • Risk Factors
  • Sweden

Status

Published

Research group

  • Lund Melanoma Study Group

ISBN/ISSN/Other

  • ISSN: 0042-9007